Kantum Pharma, Inc. — Form D
Kantum Pharma, Inc. of CONCORD, NH, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-24. The offering totals $1.5M, of which $989K was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-07-24
- Form: D
- Accession: 0001747673-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $989K
- Remaining: $511K
- Investors: 26
- Date of first sale: 2018-04-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-317595
Issuer
- Name: Kantum Pharma, Inc.
- CIK: 0001747673
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 75 SOUTH MAIN STREET, CONCORD, NH, 03301
- Phone: 603-876-6200
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jean-Francois Carbonneau | Executive Officer | Concord, NH |
| Thomas Needham | Director | Cary, NC |
| Jean-Francois Carbonneau | Director | Concord, NH |
| Sylvie Breton | Director | Concord, NH |
| Glenn Batchelder | Director | Corcord, NH |
| Glenn Batchelder | Executive Officer | Corcord, NH |
| Andrea Franz | Executive Officer | Concord, NH |
| Cory Wallenstein | Director | Concord, NH |
| Rachel Liberman | Director | Concord, NH |
| Leileata Russo | Director | Concord, NH |
Other filings by this issuer (2)
More